Subsidiaries and holdings
- CORENT74.34%
Medizorg
ActiveSummary
Medizorg has been active since 1980 and the Belgian Official Gazette contains no insolvency or warning signals. The 2026 annual accounts show equity of €56.4m and a net result of €5.9m. Equity has been growing by about 9.4% per year since 2019. Its solvency ranks better than 94% of 494 sector peers (NACE 86, financial year 2026). The computed 12-month bankruptcy probability is below 0.1% (very low).
Overview
Official details
Source: KBO- Status
- Active since 01-04-1980 Normal situation
- Activity
- Specialist medical practice NACE 86220and 1 other
- Joint committee
- 330.04 Paritair Comité voor de gezondheidsinrichtingen en -diensten · annual accounts 31-05-2026
- Establishment units
- 2.229.566.873 8400 Oostende, since 01-04-1980
- 2.229.567.467 8400 Oostende, since 01-01-1981and 60 others
- Financial year end
- 31 May
- Peppol
- Reachable since 11-12-2025
Board and ownership
Board
- Rik JoosChair
- Philippe GeysensManaging director
- Alexander BaekelandtDirector · since 28-09-2024
- Auditor
- Groupe Audit Belgium
- Holdings
- Shares in 3 companies including COVIMMO and COVENT
Financial position
- Bankruptcy probabilitywithin 12 months
- < 0.1%
Annual accounts to 31-05-2026
- Turnover
- €22.2m
- ▼ 7.0%
- Profit
- €5.9m
- ▼ 14.1%
- Equity
- €56.4m
- ▲ 6.9%
- Total assets
- €57.9m
- ▲ 6.3%
- Employees on 31-05-2026
- 29
- ▼ 14.7%
- €257,958 of overdue tax debts on 31-05-2026
Score breakdownlowers riskSector: Human health activities (NACE 86)Equity €56.4m (97.4% of total assets)Size: turnover €22.2m, 22.4 FTE, total assets €57.9mProfit of €5.9m (financial year 2026)Show the evidence
Checked score
Score 2026
94
/ 100
Excellent
Probability in this band: under 0.55%
Financially stronger than 54% of small companies in human health (NACE 86)
Financial strength · tick: 2025
Strong
Solvency
100=
equity 97.4% of total assets
Liquidity
57-8
short-term debt 2.6% · cash 5.9%
Profitability
88-2
return on assets 10.2%
Bankruptcy probability within 12 months
< 0.1%
Very low
0%0.5%1.5%4%10%≥ 25%
Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).
Last 24 months
12-2024: 0.2%highest value
01-2025: 0.2%● unchanged vs 12-2024highest value
02-2025: 0.2%● unchanged vs 01-2025highest value
03-2025: 0.2%● unchanged vs 02-2025highest value
04-2025: 0.2%● unchanged vs 03-2025highest value
05-2025: 0.2%● unchanged vs 04-2025highest value
06-2025: 0.2%● unchanged vs 05-2025
07-2025: 0.2%● unchanged vs 06-2025
08-2025: < 0.1%▼ -0.2 percentage points vs 07-2025
09-2025: < 0.1%● unchanged vs 08-2025
10-2025: < 0.1%● unchanged vs 09-2025
11-2025: < 0.1%● unchanged vs 10-2025
12-2025: < 0.1%● unchanged vs 11-2025
01-2026: < 0.1%● unchanged vs 12-2025
02-2026: < 0.1%● unchanged vs 01-2026
03-2026: < 0.1%● unchanged vs 02-2026
04-2026: < 0.1%● unchanged vs 03-2026
05-2026: < 0.1%● unchanged vs 04-2026
06-2026: < 0.1%● unchanged vs 05-2026
07-2026: < 0.1%● unchanged vs 06-2026lowest value
08-2026: < 0.1%● unchanged vs 07-2026
09-2026: < 0.1%● unchanged vs 08-2026
10-2026: < 0.1%● unchanged vs 09-2026
11-2026: < 0.1%● unchanged vs 10-2026
Credit of up to €2,200,000 on 30-day terms is acceptable
Liquidity is ample, with a current ratio of 29.23 (23.9 in 2025), above the usual 1.5. Short-term debt is 2.6% and cash 5.9% of total assets. 2.6% of the assets are financed with debt and provisions.
Calculation
The band follows from the bankruptcy probability. 10 more points roughly halve it.
| 75-100 | Excellent | under 0.55% |
| 60-74 | Healthy | 0.55% to 1.5% |
| 45-59 | Fair | 1.5% to 4.2% |
| 25-44 | Weak | 4.2% to 15.0% |
| 0-24 | Critical | over 15.0% |
Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 86, small). It does better than 77% of them on solvency, 40% on liquidity, 73% on profitability and 27% on growth.
The bankruptcy probability was computed on 02-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.
Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
Five signals.
lowers riskneutral
neutral · Latest accounts filed on time
The financial year that closed on 31-05-2026 was due by 31-12-2026 and was filed on 16-10-2026, 76 days ahead of the deadline.
NBB · 10 filingsDeviation from the deadline
2026
76 days early
2025
92 days early
2024
70 days early
2023
81 days early
2022
80 days early
2021
87 days early
2020
80 days early
← before the deadline
after the deadline →
tick = median of all Belgian filingsring = median in the sector
The company filed its last 7 accounts on average 81 days before the deadline. In the sector (NACE 86), the median for financial year 2024 was 7 days before the deadline, and 36% of those companies filed late.
Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-05-2027 and is due by 31-12-2027. Nothing is late today. The company usually files around 12 October (5 of the last 5 accounts filed within 30 days either side of that date).
Companies Code · seven monthsWhere today falls in the filing period
03-11-2026 today31-05-2027 year end31-12-2027 deadline
Key points
- Positive: Higher net result than 95% of companies in human healthsector median €68,661 · 494 companies €5.9m View
- Positive: Filed on time since financial year 2019accounts within the deadline every year 8 years View
- Positive: 8 profitable years in a rowprofit 2026: €5.9m 8 years View
- Heads a groupcompanies controlled 3 View
- Merger with MZConsultmerger on 16-04-2024 2024 View
Recent changes
- · Gazette deed Permanent representative: Werner ClaeysReappointment: GROUPE AUDIT BELGIUM (statutory auditor)
- · Gazette deed Amendment of the articles
- · Gazette deed Reappointments: Pascal Fermon, Hilde Lievens and 7 othersResignation: Willy Quintijn (lid van het beheerscomité) · Appointment: Isabelle Vanneuville (lid van het beheerscomité)
Companies linked to Medizorg
Comparable companies
These companies have the same main activity as Medizorg: specialist medical practice (NACE 86220). They are comparable in size and age: total assets between €15m and €44m, founded between 1965 and 2004.
| Company | Total assets | Turnover |
|---|---|---|
| Medizorg Merelbeke-Melle | €57.9m | €22.2m |
| Sociaal-Medisch Instituut der Zuiderkempen Heist-op-den-Berg | €32.1m | €19.3m |
| GENEESHEREN ALGEMEEN ZIEKENHUIS OUDENAARDE Oudenaarde | €20.8m | €36.2m |
| ASSOCIATION DE MEDECINS HOSPITALIERS DE LA PROVINCE DU LUXEMBOURG, 6800 LIBRAMONT Libramont-Chevigny | €15.9m | €38.2m |
| BELRO MEDICAL Waterloo | €18.8m | - |
| Practimed Tessenderlo-Ham | €44.1m | €29.2m |
| FANOURAKIS ET AYOUBI Nivelles | €15.5m | - |
Key facts about Medizorg
- What is the company number of Medizorg?
- The company number of Medizorg is 0420.397.307. The VAT number is the same number with BE in front: BE 0420.397.307.
- Where is Medizorg based?
- The registered office is at Hundelgemsesteenweg 101B, 9820 Merelbeke-Melle.Company details
- What does Medizorg do?
- According to the KBO register, the main activity is specialist medical practice (NACE 86220).
- What is the legal form of Medizorg?
- The legal form of Medizorg is Cooperative company (CV).
- When was Medizorg founded?
- Medizorg was founded on 01-04-1980.
- Is Medizorg still active?
- Yes, Medizorg is an active enterprise in the KBO register.
- How many employees does Medizorg have?
- Medizorg had an average of 22.4 full-time equivalents in financial year 2026, according to the filed annual accounts.Financials
- Which joint committee does Medizorg fall under?
- In its 31-05-2026 annual accounts, Medizorg states joint committee 330.04 (Paritair Comité voor de gezondheidsinrichtingen en -diensten).
- What is the turnover of Medizorg?
- The turnover of Medizorg was €22.2m in financial year 2026, according to the filed annual accounts.
- Is Medizorg profitable?
- In financial year 2026, Medizorg made a profit of €5.9m.
- Where can I find the annual accounts of Medizorg?
- Medizorg filed 46 annual accounts with the National Bank of Belgium, the latest for financial year 2026.
- When are the next annual accounts of Medizorg due?
- Medizorg must file the annual accounts for financial year 2027 by 31-12-2027.Timeline
Next steps
Work out how much credit to give this customer and on what payment terms.Credit check Check what to know before you do business with this company.Supplier due diligence See whether the workforce is growing and whether people stay.Employer check Check whether you can accept this company as a client under the anti-money-laundering law.AML client file Check which of your other customers you can e-invoice via Peppol.Peppol check See which support similar companies received that this one did not.Subsidies
See how customers, suppliers and banks see your own company and what to improve first.